Delivery Order SPE2DR25D2104-SPE2DR26F3UDR
- Not listed
- The Defense Logistics Agency awarded a $56.9K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) with an ultimate completion date of February 9, 2026. This competitively awarded, non-set-aside contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order valued at $28,553.91 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 15, 2025, with completion expected by January 7, 2026. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $113,445.72 by the Defense Logistics Agency on January 15, 2026, for the supply of Voranigo 40 mg tablets (30-count packaging). This firm fixed-price delivery order, with an ultimate completion date of February 6, 2026, is being fulfilled from the awardee's facility in Conshohocken, Pennsylvania. The award was made on a fully competitive, non-set-aside basis, reflecting Amerisourcebergen's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) with a completion date of February 3, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Voranigo 40 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $54,189.90 and employs firm fixed pricing, with an ultimate completion date of September 16, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for 4,570,324,284 units of Voranigo 40 mg tablets (30-count packaging) on December 18, 2025. This firm fixed-price delivery order, valued at $57,107.82 with an ultimate completion date of January 12, 2026, was competitively awarded with no set-aside designation. The contract specifies performance at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $113,445.72 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Voranigo 40 mg tablets (30-count units) with a completion date of January 26, 2026. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $52,462.98 for Voranigo 40 mg tablets (30-count) on December 3, 2025, with an ultimate completion date of December 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,556.64 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed price contract. The award was made on December 17, 2025, with an ultimate completion date of January 9, 2026, and represents a non-competitive, non-set-aside procurement. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $54,189.90 for 30-count tablets of Voranigo 40 mg on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3UDRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,454.16 to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) on January 22, 2026, with an ultimate completion date of February 12, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating full and open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under Cencora, Inc.'s (AmerisourceBergen's parent company) larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The parent company, Cencora, Inc., holds the overarching IDC framework with the Defense Logistics Agency, enabling efficient fulfillment of federal pharmaceutical requirements. AmerisourceBergen's federal contract awards demonstrate consistent capability to meet government procurement standards through competitive bidding, with contract values ranging from minimal transactions to substantial orders exceeding $45,000, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.5k | 1/21/26 |